{
  "docId": "019de072-c7f4-719d-b60b-87ffd56a191c",
  "docSlug": "e58df8a62ccd3bd6cd3ca8f1cf8222ea",
  "documentTitle": "MindMed | Results Presentation Deck | 40 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 34,
  "pageCount": 40,
  "prevPage": 33,
  "nextPage": 35,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 40,
  "notes": "SAD = Single Ascending Dose; MAD = Multiple Ascending Dose. Data shows n (%) of participants experiencing safety events.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-c7f4-719d-b60b-87ffd56a191c/34",
  "deckHref": "/decks/019de072-c7f4-719d-b60b-87ffd56a191c",
  "deckJsonHref": "/decks/019de072-c7f4-719d-b60b-87ffd56a191c.json",
  "deckAnchorHref": "/decks/019de072-c7f4-719d-b60b-87ffd56a191c#slide-34",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.3,
        "x": 0.53,
        "y": 0.65
      },
      "kind": "list",
      "text": "SAD well tolerated at doses up to 500mg/day\nMAD well tolerated at doses up to 60mg/day",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a9a76a29-1349-48ec-9c67-f6b76dddc2ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: MindMed internal study documents",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c312f679-845c-4659-92f7-a3c43d8606f0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.7,
        "x": 0.05,
        "y": 0.09
      },
      "kind": "subtitle",
      "text": "Participants received up to 650mg of MM-110 on a single day or were administered up to 180mg/day for seven days or placebo",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f04c7def-f977-474a-ab81-28d21bf3e003",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.07,
        "y": 0.255
      },
      "kind": "table",
      "text": "SAD cohort data table",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8c1d67cc-8b57-4c5a-bbac-c3e9ed3fa3f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.53,
        "y": 0.255
      },
      "kind": "table",
      "text": "MAD cohort data table",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "df8f0b6f-45b2-4c17-ae96-5d7ef832b2b1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.03
      },
      "kind": "title",
      "text": "MM-110 | Phase 1 SAD/MAD Dosing Cohorts",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4ef98896-27bd-45b8-8af3-dc6d4ae0d52c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 37,
      "from": 34,
      "beatId": "90fde132-5241-4226-8df8-b24b3fa04211",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "Slides 34-37 provide evidence and proof of Zolunicant's effectiveness.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 37,
      "from": 34,
      "name": "Hypothesis Test",
      "slug": "42-hypothesis-test",
      "bestFor": "Strategy validation, due diligence, research presentations",
      "matchId": "0d6260c9-3022-4326-9302-d14dc179c54b",
      "evidence": "Slides 34-37 present the results of the Phase 1 study.",
      "position": 2,
      "objective": "What are the results of the hypothesis test for Zolunicant's effectiveness?",
      "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)",
      "confidence": 0.6,
      "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}